Patrizia Cavazzoni, the former director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, will serve as Pfizer’s Chief Medical Officer, the company announced Monday.
Cavazzoni retired from the FDA shortly before President Trump took office in January. She now rejoins Pfizer after a previous nearly eight-year stint at the company to work in the very industry she was in charge of regulating.
In her new role, Cavazzoni will “lead Pfizer’s regulatory, pharmacovigilance, safety, epidemiology, and medical information and evidence generation, among other medical functions,” the company announced in a press release.
Doctors and leaders in the healthcare world reacted to the news on X, pointing to the “revolving door” between the pharmaceutical industry and the agencies which regulate it. (RELATED: RFK’s MAHA Army Descends On Nation’s…
